全文获取类型
收费全文 | 2137篇 |
免费 | 104篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 156篇 |
妇产科学 | 21篇 |
基础医学 | 180篇 |
口腔科学 | 57篇 |
临床医学 | 145篇 |
内科学 | 374篇 |
皮肤病学 | 51篇 |
神经病学 | 243篇 |
特种医学 | 79篇 |
外科学 | 276篇 |
综合类 | 300篇 |
一般理论 | 1篇 |
预防医学 | 58篇 |
眼科学 | 90篇 |
药学 | 92篇 |
3篇 | |
中国医学 | 13篇 |
肿瘤学 | 101篇 |
出版年
2024年 | 7篇 |
2023年 | 17篇 |
2022年 | 29篇 |
2021年 | 73篇 |
2020年 | 45篇 |
2019年 | 35篇 |
2018年 | 63篇 |
2017年 | 40篇 |
2016年 | 43篇 |
2015年 | 66篇 |
2014年 | 75篇 |
2013年 | 91篇 |
2012年 | 135篇 |
2011年 | 97篇 |
2010年 | 119篇 |
2009年 | 94篇 |
2008年 | 134篇 |
2007年 | 128篇 |
2006年 | 102篇 |
2005年 | 73篇 |
2004年 | 99篇 |
2003年 | 63篇 |
2002年 | 71篇 |
2001年 | 50篇 |
2000年 | 44篇 |
1999年 | 51篇 |
1998年 | 35篇 |
1997年 | 39篇 |
1996年 | 32篇 |
1995年 | 20篇 |
1994年 | 22篇 |
1993年 | 11篇 |
1992年 | 22篇 |
1991年 | 10篇 |
1990年 | 17篇 |
1989年 | 16篇 |
1988年 | 21篇 |
1987年 | 12篇 |
1986年 | 23篇 |
1985年 | 11篇 |
1984年 | 9篇 |
1983年 | 7篇 |
1982年 | 14篇 |
1981年 | 11篇 |
1980年 | 4篇 |
1979年 | 12篇 |
1978年 | 10篇 |
1977年 | 8篇 |
1976年 | 9篇 |
1972年 | 6篇 |
排序方式: 共有2247条查询结果,搜索用时 15 毫秒
91.
David Samoocha Ingrid AK Snels David J Bruinvels Johannes R Anema Wojtek Kowalczyk Allard J van der Beek 《BMC medical informatics and decision making》2011,11(1):10
Background
The objective of this process evaluation study was to gain insight into the reach, compliance, appreciation, usage barriers, and users' perceived effectiveness of a web-based intervention . This intervention was aimed at empowerment of disability claimants, prior to the assessment of disability by an insurance physician. 相似文献92.
Aortico-left ventricular tunnel (ALVT) is a rare congenital malformation characterized by an abnormal communication between aorta and left ventricular cavity and the child presents with features of congestive heart failure in early infancy. We report the case of a 7-day-old baby who was diagnosed as a case of ALVT by echocardiography. The child was operated successfully and echocardiographic findings were confirmed. 相似文献
93.
John Jimtha C. Radhakrishnan E. K. 《Proceedings of the National Academy of Sciences, India. Section B.》2018,88(2):755-768
Proceedings of the National Academy of Sciences, India Section B: Biological Sciences - Understanding the chemical basis of rhizobacterial-plant interaction provides immense opportunities for the... 相似文献
94.
Gopal AK Ramchandren R O'Connor OA Berryman RB Advani RH Chen R Smith SE Cooper M Rothe A Matous JV Grove LE Zain J 《Blood》2012,120(3):560-568
Hodgkin lymphoma (HL) relapsing after allogeneic stem cell transplantation (alloSCT) presents a major clinical challenge. In the present investigation, we evaluated brentuximab vedotin, a CD30-directed Ab-drug conjugate, in 25 HL patients (median age, 32 years; range, 20-56) with recurrent disease after alloSCT (11 unrelated donors). Patients were > 100 days after alloSCT, had no active GVHD, and received a median of 9 (range, 5-19) prior regimens. Nineteen (76%) had refractory disease immediately before enrollment. Patients received 1.2 or 1.8 mg/kg of brentuximab vedotin IV every 3 weeks (median, 8 cycles; range, 1-16). Overall and complete response rates were 50% and 38%, respectively, among 24 evaluable patients. Median time to response was 8.1 weeks, median progression-free survival was 7.8 months, and the median overall survival was not reached. Cough, fatigue, and pyrexia (52% each), nausea and peripheral sensory neuropathy (48% each), and dyspnea (40%) were the most frequent adverse events. The most common adverse events ≥ grade 3 were neutropenia (24%), anemia (20%), thrombocytopenia (16%), and hyperglycemia (12%). Cytomegalovirus was detected in 5 patients (potentially clinically significant in 1). These results support the potential utility of brentuximab vedotin for selected patients with HL relapsing after alloSCT. 相似文献
95.
Kim S Carrillo M Radhakrishnan UP Jagadeeswaran P 《Blood cells, molecules & diseases》2012,48(3):188-196
Hemostasis is a defense mechanism that protects an organism from bleeding in the event of injury. We have previously demonstrated the utility of the zebrafish as a model to study human hemostasis. However, there are no studies on the role of microparticles in hemostasis in early vertebrates. Studying microparticles in zebrafish may provide insight into the evolution of microparticle function in hemostasis and may lead to direct observation of these microparticles in zebrafish larvae due to transparency of the vessels. In this investigation we demonstrate the presence of cellular microparticles in fish blood by both immunostaining as well as by using zebrafish whose thrombocytes are labeled with green fluorescent protein. Further investigation showed that microparticles were also labeled by fluorescein isothiocyanate annexin V, suggesting that these particles are derived via apoptosis. A portion of the fluorescein isothiocyanate annexin V labeled microparticles was also labeled by DiI-C18. Labeling by DiI-C18 suggests that some microparticles are derived from young thrombocytes. Additionally, GpIIb antibody labels almost all thrombocyte-derived microparticles and a greater percentage of microparticles are labeled by GpIIb antibody than by DiI-C18. This suggests that thrombocyte microparticles are derived from both young and mature thrombocytes. Furthermore, the increase of microparticles by adding excessive microparticles into blood in vitro and through intravenous injections led to an increased hemostatic response. In addition, treatment with tumor necrosis factor alpha resulted in an increased number of thrombocyte microparticles and enhanced hemostasis; in contrast, treatment with zVAD-FMK, a caspase inhibitor, resulted in a decrease in thrombocyte microparticles and decreased hemostasis. We also found that thrombocyte microparticles agglutinate, along with other cells and cellular microparticles, in the presence of an excess of either ristocetin or ultra-large von Willebrand factor. Also, stimulation of von Willebrand factor release in vivo resulted in clusters of thrombocyte microparticles in the veins. Moreover, thrombocyte microparticles were the first to appear at the site of arterial injury. We found that thrombocyte microparticles are functionally equivalent to platelet microparticles. The microparticles initiate arterial thrombus formation in a von Willebrand factor-dependent manner and further enhance thrombus formation by forming clusters of microparticles in venous thrombosis. This finding may have applications for understanding the role of platelet microparticles in humans and may have diagnostic applications. 相似文献
96.
97.
98.
Sandhya Narasimhan Kuppan Gokulakrishnan Rangasamy Sampathkumar Syed Farooq Radhakrishnan Ravikumar Viswanathan Mohan Muthuswamy Balasubramanyam 《Clinical biochemistry》2010,43(10-11):815-821
ObjectiveOur work is aimed at exploring the interrelationship of oxidative stress and insulin resistance in NAFLD subjects with and without type 2 diabetes in a population-based study.MethodsSubjects [n = 200] were recruited from the Chennai Urban Rural Epidemiology Study. 1: Normal glucose tolerance (NGT) subjects without NAFLD; 2: NGT with NAFLD; 3: type 2 diabetic subjects [T2DM] without NAFLD and 4: T2DM with NAFLD. Thiobarbituric acid reactive substances (TBARS), protein carbonyl (PCC) and glutathione levels were measured by standard methods. Ultrasound of the liver was used to diagnose NAFLD.ResultsTBARS and PCC levels were significantly elevated and GSH/GSSG ratio was significantly decreased in diabetic subjects with NAFLD compared to all other groups (p trend < 0.001). Oxidative stress markers significantly associated with NAFLD even after adjusting for age, gender, BMI and glycemic status.ConclusionsIncreased oxidative stress is independently associated with NAFLD in Asian Indians without and with T2DM. 相似文献
99.
100.